Barnaby Balmforth
Amministratore Delegato presso Biofidelity Ltd.
Posizioni attive di Barnaby Balmforth
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biofidelity Ltd.
Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Amministratore Delegato | 15/02/2019 | - |
Fondatore | 15/02/2019 | - |
Storia della carriera di Barnaby Balmforth
Precedenti posizioni note di Barnaby Balmforth
Società | Posizione | Inizio | Fine |
---|---|---|---|
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Direttore operativo | 01/01/2009 | - |
Formazione di Barnaby Balmforth
University of Oxford | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 5 |
Posizioni
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biofidelity Ltd.
Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Barnaby Balmforth
- Esperienza